Buy VitaDAO (VITA)

What is VitaDAO (VITA)?

VitaDAO (VITA) is a decentralised autonomous organisation (DAO) dedicated to funding and accelerating research in the longevity space. Its mission is to extend human lifespan by democratising the funding, ownership, and commercialisation of therapeutics through community-driven governance.

How does VitaDAO (VITA) work?

VitaDAO operates on the Ethereum blockchain, utilising smart contracts to manage governance and token-based voting. Key features include:

• IP-NFTs and IPTs: Converts intellectual property into tradable digital assets, enabling decentralised ownership.
• Token Governance: Community members participate in decision-making via VITA tokens.
• Decentralised Funding: Leverages DAO structures to finance early-stage biopharma research.

VitaDAO bridges the gap between research and commercialisation by fostering collaboration between researchers, investors, and the broader community.

What are the potential use cases for VitaDAO (VITA)?

VitaDAO supports applications in biotechnology, decentralised science (DeSci), and intellectual property management, such as:

• Funding Longevity Research: Supporting early-stage projects through decentralised mechanisms.
• IP Management: Converting intellectual property into digital assets for liquidity and trade.
• Community Governance: Allowing token holders to vote on research priorities and funding.
• Research Commercialisation: Collaborating with researchers to bring innovations to market.

Key industries include biotechnology, pharmaceuticals, decentralised science, and DeFi.

What is the history of VitaDAO (VITA)?

VitaDAO was founded in 2021 as a spin-off from Molecule’s decentralised framework, addressing the limitations of traditional funding models for longevity research.

Significant Milestones:

• June 2021: Raised $5 million from a Gnosis batch auction.
• 2021: Completed the first-ever biopharma IP-to-NFT transfer.
• Community Growth: Grew to over 10,000 members.
• Funding Impact: Funded over 24 research projects with $4.2 million.

Evolution:

VitaDAO has established itself as a key player in decentralised science, leveraging blockchain technology for innovative funding and IP management. Its partnerships with academic labs and pharmaceutical companies, including Pfizer, highlight its growing influence in the longevity and biopharma sectors.

Partnerships and Features

• Collaborations: Includes partnerships with the University of Copenhagen, Molecule, and Matrix Bio.
• Innovations: First to tokenize biopharma intellectual property as NFTs.
• Community-Driven: Decisions and funding are governed by token holders, fostering transparency and inclusivity.

VitaDAO continues to evolve, attracting stakeholders across academia, industry, and decentralised ecosystems to drive the future of longevity research.